Cargando…

Awareness and Use of Complementary and Alternative Medicine in Korean Lung Cancer Patients

BACKGROUND: Complementary and alternative medicine (CAM) has been used frequently, and its use continues to increase in lung cancer patients, despite insufficient scientific of its efficacy. To investigate this situation, we analyzed the current awareness and use of CAM in Korean lung-cancer patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Joon Young, Ji, Wonjun, Choi, Chang-Min, Chung, Chaeuk, Noh, Jae Myoung, Park, Cheol-Kyu, Oh, In-Jae, Yoon, Hong In, Kim, Hyeong Ryul, Kim, Ho Young, Yeo, Chang Dong, Jang, Seung Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010414/
https://www.ncbi.nlm.nih.gov/pubmed/33287469
http://dx.doi.org/10.4046/trd.2020.0098
Descripción
Sumario:BACKGROUND: Complementary and alternative medicine (CAM) has been used frequently, and its use continues to increase in lung cancer patients, despite insufficient scientific of its efficacy. To investigate this situation, we analyzed the current awareness and use of CAM in Korean lung-cancer patients. METHODS: This prospective survey–based study was performed at seven medical centers in South Korea between August and October 2019. The survey assessed general patient characteristics and the awareness and use of CAM. We analyzed differences in the clinical parameters of patients aware and not aware of CAM and of CAM non-users and users. RESULTS: Of the 434 patients included in this study, 68.8% responded that they were aware of CAM and 30.9% said they had experienced it. In univariate analysis, the patients aware of CAM were younger with poor performance status, had advanced-stage lung cancer, received more systemic therapy, and received concurrent chemoradiation therapy (CCRT). By multiple logistic regression, younger age, poor performance status, advanced stage, and prior CCRT were identified as independent risk factors for CAM awareness. There were no significant differences in the general characteristics and cancer-associated clinical parameters of CAM non-users and users. CONCLUSION: Specific clinical parameters were associated with patients’ awareness of CAM, although there were no significantly different characteristics between CAM users and non-users.